The presence of pericardial effusion (PE) is considered to be suggestive of inflammation in suspected myocarditis. However, the incremental value of assessing for PE in addition to comprehensive cardiac magnetic resonance (CMR) imaging remains unclear.
Introduction
The diagnosis of myocarditis remains a major clinical challenge. Owing to a variety of different symptomatic presentations, such as flu-like, angina-like, or heart failure-like, 1,2 diagnosis by symptoms alone is difficult. Therefore, diagnostic work-up of patients with suspected myocarditis frequently involves endomyocardial biopsy (EMB) and/or cardiac magnetic resonance (CMR) imaging. EMB is considered as the gold standard for diagnosis of myocarditis, but it represents an invasive intervention with the potential risk of procedural complications. 3 Several studies have suggested CMR imaging as a promising alternative to EMB in patients with suspected myocarditis. 4 -13 We have previously shown that a combination of late enhancement (LE) sequences, T 2 -weighted oedema images for the assessment of global and regional oedema (oedema ratio [ER] ), as well as T 1 -weighted sequences before and after contrast injection (global relative enhancement [gRE] ) according to the 'Lake-LouiseCriteria' yielded a superior diagnostic performance when compared with relying on individual sequences. 14 Nevertheless, the reported diagnostic accuracies achieved by this approach 5, 7, 14, 15 emphasize the need for further optimization and refinement of CMR diagnostic criteria in patients with suspected myocarditis. The presence of pericardial effusion (PE) as assessed on echocardiography or CMR imaging is considered to be suggestive of inflammation in patients with suspected myocarditis. 15 A recent report demonstrated some improvement in sensitivity when using PE as an additional diagnostic CMR criterion in selected patients with virus-associated myocarditis. 16 However, this study was limited by its small sample size, highly selected patient population and did not implement gRE in the CMR imaging protocol. Thus, the potential incremental value of assessing for PE in unselected patients with suspected myocarditis in addition to established CMR criteria (Lake-Louise-Criteria) proposed by a group of CMR and myocarditis experts 15 remains unknown.
The aim of this study was to describe the incidence and extent of PE in patients with suspected myocarditis and to assess the potential incremental value of assessing for PE in addition to a comprehensive CMR imaging protocol when compared with results of EMB in this patient population.
Methods

Patient population
In this prospective cohort study, patients with suspected myocarditis were included if they fulfilled all of the following criteria: (i) new onset or persisting symptoms suggestive of myocarditis (shortness of breath, effort intolerance, fatigue, palpitations, or chest pain); (ii) evidence of recent or ongoing myocardial damage (left ventricular dysfunction, electrocardiogram [ECG] abnormalities, or elevated troponin); (iii) history of potential virus infection; and (iv) exclusion of relevant coronary artery disease on selective angiography. Patients with contraindication to cardiac catheterization, EMB, or CMR imaging were excluded. Patients were divided into two groups according to the duration of symptoms from onset to hospital admission, in order to separate patients with suspected acute myocarditis (AMC, symptoms ≤14 days) from those with suspected chronic myocarditis (CMC, symptoms .14 days).
CMR imaging and analyses
CMR imaging was performed using a 1.5-T MR scanner (Gyroscan Intera CV, Philips Medical Systems, Best, The Netherlands). The imaging acquisition and analyses protocols have been published previously in detail 14 and are only summarized in brief: retrospectively gated steady-state free precession (SSFP) cine images were acquired using a five-element phased array coil in the vertical and horizontal long-axis views, as well as short-axis stacks including the extent of both ventricles (9 -12 slices). Axial turbo spin-echo images compassing the entire heart were acquired during multiple breath-holds. Gated T 2 -weighted triple inversion recovery images in contiguous short-axis views encompassing the entire left ventricle were acquired during breath-holds using the body coil. In addition, a non-breath-hold gated T 1 -weighted fast spin-echo sequence was performed by using the body coil before and 15 s after intravenous injection of 0.1 mmol/kg of gadobutrol (Gadovist; BayerSchering, Berlin, Germany). Five identical (before and after injection of contrast agent) transverse sections including the entirety of visible myocardium were acquired. To reduce the signal from slow flowing blood, an additional T 1 -weighted fast spin-echo saturation band was positioned across the atria. LE images were acquired at mid-diastole, 15 min after the administration of a second bolus injection of gadobutrol (0.1 mmol/kg). A three-dimensional inversion recovery turbo gradientecho sequence was used for image acquisition. Constant adjustment of the inversion time was performed to achieve maximal contrast between the viable and necrotic myocardium. Images were acquired in a complete set of short-axis sections encompassing the entire left and right ventricle and two long-axis sections (horizontal and vertical views).
Image analysis was performed by experienced, blinded operators. For all quantitative analyses, the certified CMR image evaluation software was used (cmr42, Circle Cardiovascular Imaging, Inc., Calgary, AB, Canada). Standard methods of the left ventricular functional analysis were performed by manual tracing of the endo-and epicardial contours. The assessment of ER, gRE, and LE has been performed according to proposed standards 15 and has been described previously.
14 To exclude patients with non-relevant coronary stenosis but embolic or aborted myocardial infarction, isolated subendocardial LE or regional oedema with the typical coronary distribution pattern were considered to be ischaemia-mediated and inconsistent with myocarditis and therefore not included in the analyses.
The presence of PE was assessed on standard short-and long-axis SSFP images. Differentiation from epicardial fat was achieved by comparing SSFP images with T 1 -weighted spin-echo sequences, on which PE has a low signal intensity when compared with fat ( Figure 1) . Quantification of PE was performed on SSFP cine images in diastole by measurements of the maximal extent. PEs were grouped and classified as trivial (1 -3 mm), small (.3 -5 mm), moderate (.5 -10 mm), and large (.10 mm).
Coronary angiography and endomyocardial biopsies
Significant coronary artery disease (defined as stenosis .50% of vessel diameter) was excluded by coronary angiography. For EMB sampling, a myocardial biopsy forceps (Teleflex Medical Tuttlingen GmbH, Tuttlingen, Germany) was used. Five to six EMBs were taken from the left ventricle under fluoroscopic guidance. EMBs were taken from different locations within the left ventricle.
Endomyocardial biopsy analysis
All histological, immunohistological, and molecular pathological analyses diagnosing myocardial inflammation and viral infections were performed at the Department of Molecular Pathology, University Hospital Tuebingen (Tuebingen, Germany) as previously published. 3, 4, 6, 14, 17 In brief, myocardial inflammation was defined as the detection of ≥14 infiltrating leucocytes/mm 2 (CD3 T-lymphocytes and/or CD68 macrophages) in addition to enhanced human leukocyte antigen Class II expression in professional antigen-presenting immune cells. AMC requiring myocyte injury/necrosis was differentiated from CMC, which was defined by the following criteria: absence of myocyte necrosis, but the detection of interstitial fibrosis, inflammation as described above, and degeneration of neighbouring myocytes-being morphologically consistent with the formerly called 'borderline' myocarditis. Nested (reverse transcriptase) polymerase chain reaction for the detection of viral genomes was performed as previously described.
4,6
Statistical analysis
Data were tested for normal distribution by the Kolmogorow -Smirnow test. Normally distributed data are expressed as mean + SD, not normally distributed data as median and interquartile range. Proportions are expressed as the number of patients and percentages. Samples between patient groups were analysed with two-tailed unpaired Student's t-test or Mann-Whitney test. Categorical variables were compared using Fisher's exact test. Distribution of the frequency of PE within different diagnostic groups and according to clinical presentation was also compared using the Fisher's exact test. The diagnostic groups of AMC and CMC and 'Loeffler endomyocarditis' were combined into one category, and the diagnosis amyloidosis was incorporated into the category 'other diagnoses' in order to meet conditions for Fisher's exact test calculations.
Sensitivity, specificity, accuracy, positive predictive value (PPV), and negative predictive value (NPV) of the individual CMR findings (LE, gRE, ER, and PE) were determined, with immunohistological EMB results as the reference standard. The same analysis was also performed for different combinations of CMR findings.
All statistical testing was based on a two-sided a ¼ 0.05 significance level. Statistical testing and data analysis were performed with SPSS, version 16 (SPSS, Inc., Chicago, IL, USA) and GraphPad Prism, version 5.0b (Graphpad Software, San Diego, CA, USA).
Results
Clinically, AMC was suspected in 70 patients and CMC in 62 patients (median duration of symptoms 3 and 42 days, respectively, P , 0.001). In patients with clinically suspected myocarditis, the results obtained in endomyocardial biopsies revealed myocarditis in 62.9% of the overall population. AMC was found in 5.3% and CMC in 56.8%. One (0.8%) patient had Loeffler endomyocarditis. In the remaining patients, the clinically suspected diagnosis of myocarditis was not confirmed histologically (healed myocarditis in 6.0%, dilated cardiomyopathy in 15.9%, hypertrophic cardiomyopathy in 3.0%, amyloidosis in 1.5%, and other diagnoses in 10.6% of patients).
PE was found in 84 of 132 patients (64%). PE was more common in patients with clinically suspected AMC than CMC (80 vs. 45%, P , 0.001, Figure 2 ). The prevalence of PE was 64% in patients with histologically confirmed myocarditis and 56% in patients with a diagnosis other than myocarditis on EMB ( Figure 3 , P ¼ 0.09). The incidence of PE within the final EMB diagnoses ranged between 49 and 100% with no significant differences between diagnostic subgroups ( Figure 4) .
The characteristics of patients with and without PE are summarized in Table 1 . Patients with PE were significantly younger (P ¼ 0.02) and had a shorter duration of symptoms (P , 0.001) when compared with patients without PE. The majority of patients complained about heart failure symptoms including fatigue, shortness of breath, or peripheral oedema (88 vs. 75% for fatigue, PE vs. non-PE patients, P ¼ 0.08). There were no significant differences in other patterns of symptoms between the two groups. Patients with PE were more likely to exhibit ST-segment depression on electrocardiogram (P ¼ 0.02) as well as elevated levels of troponin (P , 0.001), creatine kinasemyocardial band (P ¼ 0.006), and C-reactive protein (P , 0.001).
The majority of patients (51%) had small PE (.3-5 mm), whereas 13% had trivial PE (1-3 mm), 20% moderately sized (.5-10 mm), and 14% large PE (.10 mm), P , 0.001. The distribution of different PE sizes within the total population and within AMC and CMC patients is depicted in Figure 2 . There was no significant difference in the distribution of different PE extents between AMC and CMC patients (P ¼ 0.16).
The incidence of regional and global oedema, pathological gRE, and LE has been reported previously 14 and is briefly summarized. Focal end-systolic (B and G) SSFP sequences in a four chamber view, an axial turbo spin-echo sequence depicting all four chambers (C and H ), and end-diastolic and end-systolic SSFP sequences in a short-axis view (D, E, I and J ). On SSFP images, note the thin (A, B, and E) and wider (F, G, and J ) bright layer between the dark myocardium and the pericardial sack representing PE (continues white arrows). In contrast, PE shows dark on turbo spin-echo sequences (C and H ), allowing for good discrimination from fatty tissue, which appears bright on both SSFP and turbo spin-echo sequences. The interrupted arrow points out a dark round structure representing a vessel within the bright fat tissue filling the atrioventricular groove (C).
Diagnostic value of assessing PE on CMR imaging myocardial oedema was detected in 6 (4.5%) of the 132 patients and global myocardial oedema in 61 of the 132 (46.3%) patients. An increased gRE ratio of ≥4 indicating myocardial hyperaemia was found in 81 of the 132 (61.4%) patients. Significant LE was evident in 84 (63.6%) patients. LE localization was predominantly subepicardial in 50% of patients, intramyocardial in 33.3%, predominantly subendocardial in 7.1%, and predominantly transmural in 9.5%. With regard to regional distribution, LE was found to be located anteriorly in 23.5%, septally in 30.3%, laterally in 45.5%, and inferiorly in 46.2% of patients.
Between patients with and without PE, the incidence of LE (69 vs. 54%, P ¼ 0.09), oedema (49 vs. 41%, P ¼ 0.47), and gRE (77 vs. 62%, P ¼ 0.29) was similar. The median ejection fraction was 45% (interquartile range 27-59%) with no significant differences (45, interquartile range 27-60% vs. 40, interquartile range 27-55%; P ¼ 0.32).
The diagnostic performance including sensitivity, specificity, and accuracy for the individual imaging techniques and the combination of different imaging findings are summarized in Table 2 .
For the overall cohort, the highest diagnostic sensitivity was found when greater than or equal to two of the four CMR imaging findings (gRE, ER, LE, and PE) were pathological/positive. This was also true for both patient cohorts with suspected AMC and CMC.
The highest specificity was achieved by using a three out of four approach, when considering only PE extents of .5-10 or .10 mm for the total population, .5-10 mm for AMC patients, and .10 mm for CMC patients. The best PPV was found when applying a three out of four approach considering only PE extents of .5-10 mm for the total population, AMC, and CMC patients. The 'LakeLouise-Criteria' (two out of three including ER, gRE, and LE) yielded superior or equal NPV when compared with other CMR criteria. This finding was consistent within the total population and both AMC and CMC patients. Importantly, no other combination of CMR findings yielded superior accuracies than achieved by applying the 'Lake-Louise-Criteria'. This finding was independent of PE extent or any subgroup analyses ( Table 2) .
Discussion
In this study, we have demonstrated that PE is a frequent finding on CMR imaging in patients with suspected myocarditis and is found more often in patients with a shorter duration of symptoms when compared with those with more chronic symptoms. However, the presence of PE is not specific for the diagnosis of myocarditis obtained in EMB. In particular, there were no significant differences in the occurrence and extent of PE between the group of patients with EMB-proven myocarditis and those with non-myocarditis diagnoses. As a consequence, the use of PE as an additional diagnostic CMR criterion does not improve the overall diagnostic performance of CMR imaging in the context of clinically suspected myocarditis.
Our study is unique in that it is the first evaluating the diagnostic performance of integrating PE into a comprehensive CMR imaging protocol in unselected patients with clinical suspicion of myocarditis.
PE has been reported in a significant portion of patients with myocarditis and its presence is considered to be supportive for active inflammation. Previously, Ong et al. 16 have evaluated the diagnostic potential of assessing for PE in addition to LE imaging only in a highly selected population of patients with virus-induced myocarditis in EMB. The authors could demonstrate that PE, used as an additional diagnostic criterion, improved the sensitivity of CMR imaging for myocarditis from 46 to 66%. Since patients without myocarditis were not included into their study, the study could not provide any information on potential changes in specificity, PPV, NPV, or accuracy. We 14 and others 5, 7, 14, 15 have previously shown that, at present, a two out of three approach according to the 'Lake-Louis-Criteria' as described above is considered to result in the best diagnostic performance of CMR imaging for suspected myocarditis. However, we could recently show that this approach is still suboptimal, and that there is a need for improvement of CMR criteria for the diagnosis of myocarditis. 14 Therefore, assessing the incremental value of the potential criterion PE when compared with the above-mentioned two out of three approaches was the primary objective of this work. Adding PE and applying a two, three, or four out of four criteria approach can improve specificity, but reduces at the same time sensitivity and does therefore not enhance overall diagnostic performance of CMR imaging as defined by accuracy. Fundamentally, if improvements in diagnostic accuracy should be achieved, any CMR finding that is integrated into a diagnostic reporting algorithm in the context of suspected myocarditis needs to fulfil the following: (i) the finding should be fairly specific to the diagnosis of myocarditis and (ii) the finding should reflect a sensitive phenomenon occurring in most cases of myocarditis. Unfortunately, the CMR finding of PE does not fulfil either requirement. PE proved not to be specific to myocarditis. Apart from viral or immune-mediated myopericarditis, numerous systemic inflammatory conditions such as rheumatoid diseases, 18 cancer, 19 or chronic heart failure 20 can lead to increased permeability and in turn capillary leak resulting in the development of PE. In our study population, PE was found in 56% of patients with other EMB diagnosis than myocarditis, e.g. around half of the patients with dilated or hypertrophic cardiomyopathy presented with PE at the time of admission. PE in heart failure has been described in several previous studies, 20 -22 albeit the incidence in our population was higher compared with previous reports (incidence of PE ranging from 12 to 20% 20 -22 ). This discrepancy might be explained by the applied assessment method. Previous studies were mainly based on echocardiographic evaluation of PE presence, whereas Ong et al. 16 could demonstrate that CMR is superior to echocardiography in detecting PE. Aetiology of PE, in our study, remains unknown and can only be speculated upon. A common understanding of PE in the context of myocarditis is the concomitant inflammation of the pericardium, whether this is virus or non-virus related. In contrast, PE in heart failure patients is often believed to be a consequence of decreased reabsorption due to increased systemic venous pressure as generally seen in congestive heart failure. 23 These assumptions about the different causes of PE appear to be less obvious in light of the fact that heart failure is associated with systemic inflammation. Recently, Frohlich et al. 20 could
show that, in patients with heart failure, the occurrence of PE is associated with higher levels of C-reactive protein and leucocytes. This is in line with our results and supports the hypothesis that the systemic inflammation occurring in severe heart failure might induce capillary leakage, thereby contributing to pericardial fluid accumulation in this population. The discussion above underlines that neither the sole phenomenon of PE nor the pathophysiological processes causing PE are specific to certain diseases or conditions, explaining the limited diagnostic role of PE in our study. The second unfulfilled requirement of the diagnostic criterion of PE refers to an inadequate sensitivity for detecting myocarditis. Although often considered to be suggestive of inflammation/myocarditis, PE is found in only 32-57% of patients with suspected or EMB-proven myocarditis, 16,24 -26 with a slightly higher incidence of PE in our population (64%). This suggests that, in a relevant proportion of patients, viral or non-viral inflammation of the myocardium does not affect the pericardium. The high number of myocarditis positive and PE negative patients might also be a matter of different time courses of pericardial and myocardial involvement. Especially in patients with a longer duration of symptoms, PE might have been seen only in the beginning of the disease and might have had disappeared already at the time of hospital admission. In this study, we have demonstrated that PE is associated with a significantly shorter duration of symptoms, more pronounced ECG changes, and higher levels of troponin. In other terms, PE might be related to a higher degree of acuteness and manifestation of the disease. Especially in patients with suspected CMC, isolated persistence of myocardial but not pericardial inflammation over time could be possible, which would contribute to the low sensitivity especially in this subgroup of patients. However, neither in suspected CMC nor AMC, PE was found to add to the diagnostic performance of CMR imaging. Likewise, according to Imazio et al.
27
, only 15% of patients with pericarditis exhibit signs of myocardial involvement.
Finally, it should be noted that the extent of PE was not associated with specific diagnoses. Hence, considering PE extent instead of mere presence as a criterion did also not result in any relevant changes in the diagnostic performance.
Limitations
To date, the diagnostic gold standard of myocarditis is histological, immunohistological, and molecular pathologic analyses of EMB. However, limitations in EMB diagnostics are given by some degree of sampling error of EMB, which might have impact on the result of this study. CMR guided targeted EMB might have improved the diagnostic performance of this reference standard, but was not part of the applied protocol.
Also, since we did not perform pericardiocentesis in this study, we can only speculate on different aetiologies of PE in our patients. At present, it remains unknown, whether a diagnostic pericardiocentesis in these patients could improve overall diagnostic performance.
Conclusion
In summary, PE and myocarditis can coexist, also because they share common aetiological agents such as cardiotropic viruses. Nevertheless, only about half of the patients with EMB-proven myocarditis show PE on CMR at the time of hospital admission, and a significant proportion of patients develop PE for other reasons than EMBproven viral or non-viral myocarditis. These observations explain why PE as an additional diagnostic CMR criterion might improve specificity, but at the same time decreases sensitivity and accuracy and is therefore unlikely to contribute to desired future improvements in the diagnostic performance of CMR imaging in patients with suspected myocarditis.
